Molecular Diagnostics in Diabetes: From Biomarkers to Clinical Applications

Dear Colleagues,

Diabetes is one of the most widespread growing chronic diseases worldwide, and left untreated, it is associated with significant complications and healthcare costs. Recent advances in molecular diagnostics have created new possibilities for the early detection and personalized management of diabetes and its complications. A better understanding of circulating molecular biomarkers, including cell-free DNA (cfDNA), microRNAs, and other molecular indicators, offers promising minimally invasive disease monitoring and treatment approaches. In this Special Issue, we aim to share the latest findings in diagnostic and therapeutic biomarkers in diabetes, and to explore their translational potential in clinical practice. We invite researchers and clinicians to submit original articles, reviews, and meta-analyses on new molecular diagnostic methods and their practical use in diabetes diagnosis and treatment. Join us in advancing diabetes care through innovative molecular diagnostics.

Dr. Robert Stawski
Dr. Konrad Walczak
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.